As the early RA cohort also included UA patients, ACPA and RF positivity differs between both cohorts: 40% of the early RA patients were ACPA and RF positive, compared with 72% and 68% of the established RA patients. The gene discussed is PRTN3; the disease is rheumatoid arthritis.